Fingerprint
Dive into the research topics of 'A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically